Latest PEG ratio for Forward Pharma A/S: -560.08 — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow-560.08
The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.
Forward Pharma A/S (FWP) currently reports a PEG ratio of -560.08. That is below the Healthcare sector average of 11.52. Use the charts on this page to explore Forward Pharma A/S's PEG ratio history and peer comparisons.
Forward Pharma A/S's PEG ratio of -560.08 is lower than the Healthcare sector average of 11.52. That is roughly 4963.4% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
The PEG ratio is a valuation multiple that relates Forward Pharma A/S's market price to a fundamental measure such as earnings, sales, or book value. At -560.08, FWP can look expensive or cheap only in context — versus its own history, growth rate, and Healthcare peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.
Start with the current PEG ratio of -560.08, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 11.52. From there, open related valuation or income-statement pages for Forward Pharma A/S, and consider following FWP for alerts when major investors trade the stock.
Forward Pharma A/S is classified in the Healthcare sector. On PEG ratio, it currently shows -560.08 versus a sector average near 11.52. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing FWP with unrelated industries.